Instituto Rosenbusch

Instituto Rosenbusch Goodwill/Assets

Goodwill to Total Assets Ratio of Instituto Rosenbusch (ROSE2.BA) as of Oct 19, 2026.

Goodwill/Assets

-

Last updated:

Goodwill to Total Assets Ratio of Instituto Rosenbusch is 2026 - . Goodwill to Total Assets Ratio of Instituto Rosenbusch was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Instituto Rosenbusch Stock analysis

What does Instituto Rosenbusch do? Instituto Rosenbusch SA, based in Buenos Aires, Argentina, operates in the Health Care sector, specifically in Pharmaceuticals. The company manufactures and markets veterinary products, including pharmaceuticals such as antibiotics, antimastitics, antimycotics, antiparasites, vitamins, and minerals, as well as biological products like vaccines for cattle, equines, pigs, sheep, and dogs. It also engages in meat slaughtering and provision. Listed on 21 February 2008, the company owns subsidiaries including Laboratorios Rosenbusch SA, Laboratorios Bolivar SA, and Rosenbusch Paraguay SA. Instituto Rosenbusch is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Instituto Rosenbusch stock

On Eulerpool you can find the complete historical development of Goodwill to Total Assets Ratio Instituto Rosenbusch since 2006 – with annual values, charts, and detailed analysis.

The Goodwill/Assets ratio shows what percentage of total assets consists of acquisition goodwill. High ratios may indicate impairment risk.

Goodwill to Total Assets Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill to Total Assets Ratio's Instituto Rosenbusch historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Instituto Rosenbusch

All Key Metrics — Instituto Rosenbusch